Our data demonstrated for the first time that hyperglycemia and diabetes modulate hypoxic signaling and oxygen consumption rate by mechanisms involving disruption of PHDs-HIF-α via the upregulation of the p53/TIGAR signaling pathways. The gene discussed is TP53; the disease is diabetes mellitus.